U.S. Logistics Stock News

In January 2026, SEALSQ Corp reported preliminary unaudited 2025 revenue of US$18,000,000, reiterated very large 2026 revenue growth guidance, and unveiled multiple quantum-security initiatives including an India-focused semiconductor joint venture and potential multi-stage investment in French quantum firm Quobly. Together with live post-quantum robotics tests and participation in high-profile policy and investor forums, these moves position SEALSQ as an increasingly influential player at...

What FIGS’ Recent Performance Tells You FIGS (FIGS) has been catching investor attention after a sharp total return over the past year, paired with annual revenue of about US$581.0m and net income of roughly US$17.6m. See our latest analysis for FIGS. At a share price of US$11.60, FIGS has seen a sharp 47.6% 90 day share price return and a 95.3% 1 year total shareholder return, suggesting momentum has picked up even after a recent 5.9% 1 day pullback. If FIGS has piqued your interest, it...

Recent share performance snapshot Without a specific news catalyst driving trading today, United Therapeutics (UTHR) still gives you a fair bit to work with based on recent price moves and the latest fundamental snapshot. The stock closed at US$464.93, with a 1 day return of about a 1.5% decline and a 7 day move of roughly a 3.8% decline. Over the past month the share price shows about a 9% decline, while the past 3 months reflect roughly a 7.3% gain. On the fundamentals side, United...

TE Connectivity (TEL) is back in focus after recent analyst commentary and investor letters highlighted its role in automotive and industrial connectivity, along with its exposure to AI related technology, prompting fresh interest in the stock. See our latest analysis for TE Connectivity. TE Connectivity’s recent 7 day share price return of about 4% and 30 day share price return above 8%, alongside a 1 year total shareholder return near 68%, suggests momentum building around its role in...

Why 10x Genomics is back on investors’ radar 10x Genomics (TXG) has attracted fresh attention after pairing a mixed 2025 revenue update with new collaborations in autoimmune disease, oncology, immuno-oncology and transplant research across several major medical institutions. See our latest analysis for 10x Genomics. The cluster of new collaborations around autoimmune disease, oncology, immuno-oncology and transplant research has arrived alongside a 30-day share price return of 30.29% and a...

Earlier this week, Eve Holding, through its subsidiary EVE UAM, LLC, entered into a syndicated credit agreement that provided a US$150,000,000 advance from a group of international banks to fund supplier payments and core production and sales activities, with repayments scheduled over four and five years at Term SOFR plus 3.10% interest. A key detail is that Eve Holding has guaranteed EVE UAM’s obligations under this facility, signaling a strong parent-level commitment to supporting the...

Why Ensign Group is on investors’ radar today Ensign Group (ENSG) is drawing attention after recent share price moves, with the stock last closing at $180.57. Investors are weighing that price against the company’s earnings profile and recent return history. See our latest analysis for Ensign Group. The recent 1 day share price decline of 1.62% to $180.57 comes after a 7 day share price return of 3.85%, while the 1 year total shareholder return of 32.22% suggests momentum has been building...

If you are wondering whether Ziff Davis is a bargain or a value trap at its current US$37.48 share price, you are not alone. The stock has returned 3.6% over the last 7 days and 4.8% over the last 30 days. Year to date it is at 10.3%, with a 31.8% decline over 1 year and a 56.1% decline over 3 years. These mixed returns sit against an ongoing stream of corporate updates and portfolio activity that continue to keep Ziff Davis on investors' watchlists. Together, these developments help explain...

If you are wondering whether Super Micro Computer's share price still lines up with its underlying value, this article will walk through what the current numbers actually suggest. The stock recently closed at US$32.64, with returns of 8.2% over 7 days, 11.1% over 30 days, 5.4% year to date, 5.9% over 1 year, and a very large 3 year and 5 year return that is more than 7x the starting point. Recent news coverage has focused on Super Micro Computer's role in high performance computing and AI...

If you are wondering whether Archer Aviation’s current share price lines up with its underlying value, you are not alone. This article is built to help you frame that question clearly. The stock recently closed at US$8.86, with returns of 0.6% over 7 days, 16.9% over 30 days, 9.0% year to date and 0.5% over 1 year, while the 3 year return sits at a very large 215.3% and the 5 year return at a 16.4% decline. Recent attention around Archer Aviation has centered on the broader electric air taxi...

If you are wondering whether ICON's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Over shorter timeframes, ICON's share price has moved only modestly, with a 0.7% return over the last week and 1.8% over the last month, while the year to date return of 3.2% decline and 1 year return of 7.8% decline contrast with a 21.1% decline over 3 years and 15.6% decline over 5 years. These returns sit...

If you are wondering whether RTX is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about future value. RTX recently closed at US$201.92, with returns of 7.1% over 7 days, 14.0% over 30 days, 7.8% year to date, 69.8% over 1 year, 129.0% over 3 years and 235.1% over 5 years. This naturally raises questions about how much optimism is already reflected in the stock. Recent headlines around RTX have focused on the company...

Citizens Financial Group previously announced that it would release its fourth quarter and full-year 2026 results on January 15, 2027, with a press release at approximately 6:20 a.m. Eastern and a conference call at 9:00 a.m., both accessible via its investor relations website. Beyond the timing update, Citizens has outlined an ambitious plan centered on substantial projected earnings growth, expanding private banking, expiring legacy interest rate hedges, and efficiency gains from AI, all...

Why CVS Health Stock Is Back in Focus After Its Latest Dividend Decision CVS Health (CVS) is drawing fresh attention after its board approved a quarterly dividend of $0.665 per share, payable on February 2, 2026, to shareholders of record on January 22. This latest dividend affirmation comes as investors weigh the company’s broad health solutions model, recent commentary around Medicare Advantage exposure, and expectations heading into the upcoming fourth quarter 2025 earnings release. See...

Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has helped lift investor interest in the stock. See our latest analysis for Oddity Tech. At a share price of $35.34, Oddity Tech has seen a 4.56% 1 day share price return, but weaker 30 day and 90 day share price returns of 16.34% and 30.50%, with a 1 year total shareholder return of 19.39%. This...

Membership surge and profitability target come into focus Clover Health Investments (CLOV) recently reported a 53% year over year jump in Medicare Advantage membership to about 153,000 members, alongside guidance for its first full year of GAAP net income profitability in 2026. Management links this outlook to stronger member retention above 95%, improved operational efficiencies, and higher Star Ratings. Its flagship PPO plan is highlighted as a key contributor during a period of wider...

Why Quaker Chemical Is On Investors’ Radar Today Quaker Chemical (KWR) has drawn fresh attention after a recent share move, with the stock up about 13% over the past month and roughly 21% in the past 3 months. See our latest analysis for Quaker Chemical. The recent 12.97% 1 month share price return and 21.04% 3 month share price return suggest momentum has picked up again, even though the 5 year total shareholder return of a 39.05% loss shows a much tougher longer term journey. If Quaker...

If you are wondering whether Compass is still reasonably priced after a strong run, this article will walk you through what the current share price could imply about its underlying value. The stock closed at US$12.86, with returns of 0.2% over the last 7 days, 22.1% over the last 30 days, 22.5% year to date and 90.2% over the last year, so recent moves are front of mind for many investors. Recent news coverage has focused on Compass as a listed real estate brokerage platform, highlighting...

Why Brookdale’s latest occupancy and refinancing updates matter Brookdale Senior Living (BKD) has drawn fresh investor attention after reporting higher fourth quarter 2025 occupancy and above seasonal December performance, alongside a US$600 million refinancing that reshapes its near term debt profile. See our latest analysis for Brookdale Senior Living. The refinancing news and occupancy gains have come alongside a sharp shift in sentiment, with an 8.44% 1 day share price return, a 40.55% 90...

Earlier this week, MongoDB, Inc. expanded its AI capabilities by integrating Voyage AI’s embedding and reranking models directly into its core database and Atlas platform, while also launching automated embedding tools, multimodal support including video, and an AI assistant for Compass and Atlas Data Explorer. This move effectively turns MongoDB into a more unified data intelligence layer, allowing developers to keep operational data and vector search together, simplify architectures, and...

GE HealthCare Technologies (GEHC) is back in focus after announcing a collaboration with NXP Semiconductors to bring edge AI into acute care, including new anesthesia and neonatal monitoring concepts showcased at CES 2026. See our latest analysis for GE HealthCare Technologies. At a share price of $81.75, GE HealthCare’s recent momentum has cooled, with a 7 day share price return of 6.34% decline and a 30 day share price return of 0.93% decline. However, the 90 day share price return of...

Minerals Technologies Inc. recently expanded its paper and packaging business in Asia by starting up three new satellite plants in 2025, doubling capacity at an existing Indian facility, and planning to commission another satellite in China in early 2026, deepening its presence across China, India, Indonesia, Japan, and Thailand. An interesting angle is that about half of these new and expanded Asian satellites are dedicated to packaging applications, aligning the business more closely with...

Conference spotlight and why investors are watching LightPath Technologies (LPTH) is set to present at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, and that upcoming appearance is drawing fresh attention from investors. See our latest analysis for LightPath Technologies. That conference appearance comes after a sharp run in the shares, with a 30 day share price return of 82.70% and a 1 year total shareholder return of 273.00%. This suggests...

Sify Technologies Limited has released its third-quarter 2025 results, reporting sales of ₹11,596 million versus ₹10,491 million a year earlier, alongside a net loss of ₹329 million compared with ₹258 million previously. Beyond the headline loss, the company’s 11% revenue increase and strong demand for data center co-location capacity highlight how its AI and hyperscaler-focused infrastructure build-out is reshaping its business mix. We’ll now examine how this combination of higher revenue...